An Examination of Policy, Practice, Care, and Innovation in the U.S. and France
نام ساير پديدآوران
Sharp, Lesley
وضعیت نشر و پخش و غیره
نام ناشر، پخش کننده و غيره
Columbia University
تاریخ نشرو بخش و غیره
2020
مشخصات ظاهری
نام خاص و کميت اثر
241
یادداشتهای مربوط به پایان نامه ها
جزئيات پايان نامه و نوع درجه آن
Ph.D.
کسي که مدرک را اعطا کرده
Columbia University
امتياز متن
2020
یادداشتهای مربوط به خلاصه یا چکیده
متن يادداشت
Sickle cell disease (Fr: la drépanocytose) is an inherited blood disorder with over a century of biomedical history in the United States. In turn, with recent decades of migration, it has become the most common genetic disease in France. For those with sickle cell disease who also live in high-income countries, the past fifty years have transformed a fatal disease of childhood into a chronic, but still life-shortening condition. In countries like the U.S. and France, where sickle cell disease also disproportionately affects disadvantaged minorities and immigrants, scientific and clinical knowledge production around sickle cell disease has become entwined with race- and class-based history and politics. This research offers ethnographic understandings of how families and health care providers are negotiating the available options to treat sickle cell disease, including the high-risk undertaking of hematopoietic cell transplantation, in a moment when most children in high-income settings are expected to reach adulthood.
موضوع (اسم عام یاعبارت اسمی عام)
موضوع مستند نشده
Anticipation
موضوع مستند نشده
Care
موضوع مستند نشده
La drépanocytose
موضوع مستند نشده
Medical anthropology
موضوع مستند نشده
Politics
موضوع مستند نشده
Sickle cell disease
نام شخص به منزله سر شناسه - (مسئولیت معنوی درجه اول )